Inno Biologica

InnoBiologica is a biotechnology company focused on overcoming the blood-brain barrier (BBB) to deliver therapeutic agents to the central nervous system. The company utilizes its proprietary Inno-BBB platform, which leverages advanced nanotechnology and targeted ligands to transport a wide range of modalities, including small molecules, peptides, and biologics, into the brain. By enhancing the permeability and selectivity of drug delivery, InnoBiologica aims to develop effective treatments for high-met-need neurological conditions such as Alzheimer's disease, Parkinson's disease, and brain tumors. The company's approach combines expertise in nanomedicine and molecular biology to create a versatile pipeline of brain-targeted therapies.